Important safety considerations include: If you use oral contraceptives, use additional barrier contraception for 4 weeks after starting treatment and after each dose increase Not recommended during pregnancy or breastfeeding Increased risk of hypoglycaemia if used with insulin or sulfonylureas Monitor for signs of pancreatitis or gallbladder disease (severe abdominal pain, persistent vomiting) Regular diabetic retinopathy screening is recommended Arrange baseline and follow-up blood tests with your GP or a private laboratory to monitor HbA1c, renal function, and lipid profile according to NICE guidance
Prepared solution: Stability depends on concentration, pH, diluent, sterility, container, preservatives, and temperature
The injection is typically administered into the upper arm or buttock, and the procedure takes only a few minutes
For a Hypertensive Emergency (I16.1), codes for the underlying hypertension and the specific acute organ damage (e.g., stroke, CKD stage) must also be included